Document Detail

Protective effect of Umbelliferone on membranous fatty acid composition in streptozotocin-induced diabetic rats.
MedLine Citation:
PMID:  17477917     Owner:  NLM     Status:  MEDLINE    
Umbelliferone (UMB), a natural antioxidant, is benzopyrone in nature, and it is present in the fruits of golden apple and bitter orange. Earlier we evaluated and reported the effect of Umbelliferone on antidiabetic, antioxidant and antihyperlipidemic properties, and this study was designed to evaluate the effect of Umbelliferone on membrane fatty acid composition and histopathology of liver and kidney of control and streptozotocin (STZ) diabetic rats. Male albino Wistar rats (180-200 g) were made diabetic by an intraperitonial administration of STZ (40 mg/kg). The control and diabetic rats were treated with Umbelliferone and glibenclamide dissolved in 10% dimethyl sulfoxide for 45 days. Diabetic rats had decreased insulin and increased glucose, and increased levels of thiobarbituric acid reactive substances, lipid hydroperoxides and conjugated dienes. The levels of palmitic, stearic and oleic acids increased and the levels of linolenic and arachidonic acids decreased in diabetic rats as compared with control rats. Thus, the saturated fatty acids and monounsaturated fatty acids increased and the polyunsaturated fatty acids decreased in diabetic rats. Diabetic rats had decreased liver weight and increased activities of alanine transaminase and aspartate transaminase; increased kidney weight and urine albumin, and decreased levels of urea, uric acid and creatinine in the urine. Histopathological studies of liver and kidney in diabetic rats showed fatty changes surrounding portal triad; enlargement of lining cells of tubules, fatty infiltration, large area of hemorrhage and lymphocyte infiltration. Treatment with Umbelliferone and glibenclamide reversed these changes to near normalcy. Our results showed that Umbelliferone has a protective effect on membrane fatty acid composition of liver and kidney as supported by antioxidant and antihyperlipidemic effects of Umbelliferone reported earlier as evidenced by improved histopathological changes, hepatic and nephritic markers, indicating recovery from the risk of diabetic complications.
Balakrishnan Ramesh; Periyasamy Viswanathan; Kodukkur Viswanathan Pugalendi
Related Documents :
3814347 - 1,4-butanediol and ethanol compete for degradation in rat brain and liver in vitro.
1110477 - Effects of a protein-free diet on amino acids and sex hormones of rats during the early...
18514057 - L-gln and l-ser suppress the d-galactosamine-induced il-18 expression and hepatitis.
7344877 - Age dependency of rolitetracycline-induced hepatic steatosis.
18214757 - The use of lipid-based formulations to increase the oral bioavailability of panax notog...
24837947 - Soluble and insoluble phenolic compounds and antioxidant activity of immature calamondi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-04-10
Journal Detail:
Title:  European journal of pharmacology     Volume:  566     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-05-28     Completed Date:  2007-09-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  231-9     Citation Subset:  IM    
Department of Biochemistry, Faculty of Science, Rajah Muthiah Medical College and Hospital, Annamalai University, Annamalainagar - 608 002, Tamilnadu, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alanine Transaminase / metabolism
Antioxidants / pharmacology*
Aspartate Aminotransferases / metabolism
Blood Glucose / analysis
Diabetes Mellitus, Experimental / drug therapy,  metabolism*,  pathology
Fatty Acids / metabolism*
Insulin / blood
Kidney / drug effects,  metabolism,  pathology
Lipid Peroxides / metabolism
Liver / drug effects,  metabolism,  pathology
Rats, Wistar
Thiobarbituric Acid Reactive Substances / metabolism
Umbelliferones / pharmacology*
Reg. No./Substance:
0/Antioxidants; 0/Blood Glucose; 0/Fatty Acids; 0/Lipid Peroxides; 0/Thiobarbituric Acid Reactive Substances; 0/Umbelliferones; 11061-68-0/Insulin; 18883-66-4/Streptozocin; 93-35-6/7-hydroxycoumarin; EC Aminotransferases; EC Transaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants.
Next Document:  Effect of two novel CGRP-binding compounds in a closed cranial window rat model.